192 related articles for article (PubMed ID: 21320077)
21. Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.
Henningsson AJ; Gyllemark P; Lager M; Skogman BH; Tjernberg I
APMIS; 2016 Nov; 124(11):985-990. PubMed ID: 27651242
[TBL] [Abstract][Full Text] [Related]
22. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis.
Rupprecht TA; Pfister HW; Angele B; Kastenbauer S; Wilske B; Koedel U
Neurology; 2005 Aug; 65(3):448-50. PubMed ID: 16087912
[TBL] [Abstract][Full Text] [Related]
23. CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.
Hytönen J; Kortela E; Waris M; Puustinen J; Salo J; Oksi J
J Neuroinflammation; 2014 Jun; 11():103. PubMed ID: 24920219
[TBL] [Abstract][Full Text] [Related]
24. [CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine].
Rupprecht TA; Lechner C; Tumani H; Fingerle V
Nervenarzt; 2014 Apr; 85(4):459-64. PubMed ID: 24682168
[TBL] [Abstract][Full Text] [Related]
25. Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.
Leypoldt F; Höftberger R; Titulaer MJ; Armangue T; Gresa-Arribas N; Jahn H; Rostásy K; Schlumberger W; Meyer T; Wandinger KP; Rosenfeld MR; Graus F; Dalmau J
JAMA Neurol; 2015 Feb; 72(2):180-6. PubMed ID: 25436993
[TBL] [Abstract][Full Text] [Related]
26. The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children.
Skogman BH; Lager M; Henningsson AJ; Tjernberg I
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2221-2229. PubMed ID: 28730535
[TBL] [Abstract][Full Text] [Related]
27. Prospective study on the chemokine CXCL13 in neuroborreliosis and other aseptic neuroinfections.
Pícha D; Moravcová L; Smíšková D
J Neurol Sci; 2016 Sep; 368():214-20. PubMed ID: 27538636
[TBL] [Abstract][Full Text] [Related]
28. [CXCL-13 as a biomarker in the diagnostics of neuroborreliosis].
Waiß C; Kindler W; Ströbele B; Aspöck C; Oberndorfer S
Nervenarzt; 2017 Jun; 88(6):635-641. PubMed ID: 28184973
[TBL] [Abstract][Full Text] [Related]
29. Intrathecal Th17- and B cell-associated cytokine and chemokine responses in relation to clinical outcome in Lyme neuroborreliosis: a large retrospective study.
Gyllemark P; Forsberg P; Ernerudh J; Henningsson AJ
J Neuroinflammation; 2017 Feb; 14(1):27. PubMed ID: 28148307
[TBL] [Abstract][Full Text] [Related]
30. [Diagnostic relevance of the chemokine CXCL13 and anti-C6 peptide antibodies in patients with neuroborreliosis].
Pícha D; Moravcová L; Smíšková D
Epidemiol Mikrobiol Imunol; 2017; 66(2):80-85. PubMed ID: 28691831
[TBL] [Abstract][Full Text] [Related]
31. Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid.
van Burgel ND; Bakels F; Kroes AC; van Dam AP
J Clin Microbiol; 2011 May; 49(5):2027-30. PubMed ID: 21367992
[TBL] [Abstract][Full Text] [Related]
32. Borrelia garinii induces CXCL13 production in human monocytes through Toll-like receptor 2.
Rupprecht TA; Kirschning CJ; Popp B; Kastenbauer S; Fingerle V; Pfister HW; Koedel U
Infect Immun; 2007 Sep; 75(9):4351-6. PubMed ID: 17562761
[TBL] [Abstract][Full Text] [Related]
33. Borrelia antibodies in children evaluated for Lyme neuroborreliosis.
Bennet R; Lindgren V; Zweygberg Wirgart B
Infection; 2008 Oct; 36(5):463-6. PubMed ID: 18791841
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis.
Rupprecht TA; Manz KM; Fingerle V; Lechner C; Klein M; Pfirrmann M; Koedel U
Clin Microbiol Infect; 2018 Dec; 24(12):1234-1240. PubMed ID: 29674128
[TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection.
Bremell D; Mattsson N; Edsbagge M; Blennow K; Andreasson U; Wikkelsö C; Zetterberg H; Hagberg L
BMC Neurol; 2013 Jan; 13():2. PubMed ID: 23294475
[TBL] [Abstract][Full Text] [Related]
36. Specificity and Diagnostic Utility of Cerebrospinal Fluid CXCL13 in Lyme Neuroborreliosis.
Eckman EA; Clausen DM; Herdt AR; Pacheco-Quinto J; Halperin JJ
Clin Infect Dis; 2021 May; 72(10):1719-1726. PubMed ID: 32221538
[TBL] [Abstract][Full Text] [Related]
37. [Cytokine CXCL13--a possible early CSF marker for neuroborreliosis].
Rupprecht TA; Koedel U; Angele B; Fingerle V; Pfister HW
Nervenarzt; 2006 Apr; 77(4):470-3. PubMed ID: 16308679
[TBL] [Abstract][Full Text] [Related]
38. Cerebrospinal Fluid Pleocytosis and Elevated C-X-C Motif Chemokine Ligand 13 Value Predict Lyme Borreliosis in Children With Facial Palsy.
Pöyhönen H; Lähdesmäki T; Hytönen J; Peltola V
Pediatr Infect Dis J; 2019 Dec; 38(12):1195-1198. PubMed ID: 31634297
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica.
Zhong X; Wang H; Dai Y; Wu A; Bao J; Xu W; Cheng C; Lu Z; Qiu W; Hu X
J Neuroimmunol; 2011 Dec; 240-241():104-8. PubMed ID: 22036953
[TBL] [Abstract][Full Text] [Related]
40. CXCL13 in laboratory diagnosis of Lyme neuroborreliosis-the performance of the recomBead and ReaScan CXCL13 assays in human cerebrospinal fluid samples.
Haglund S; Lager M; Gyllemark P; Andersson G; Ekelund O; Sundqvist M; Henningsson AJ
Eur J Clin Microbiol Infect Dis; 2022 Jan; 41(1):175-179. PubMed ID: 34626256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]